share_log

Needham:维持CRISPR Therapeutics(CRSP.US)评级,由买入调整至买入评级, 目标价由90.00美元调整至88.00美元。

Zhitong Finance ·  May 9 09:46

Needham:维持CRISPR Therapeutics(CRSP.US)评级,由买入调整至买入评级, 目标价由90.00美元调整至88.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment